Media & Events
Get To Know Us
Board Of Directors
A Welcoming CDMO: It's The Texas In Us
cGMP Mammalian Cell Culture
cGMP Microbial Fermentation
Mammalian Cell Culture Development
Cell Therapy Development
Microbial Fermentation Development
Downstream Process Development
Pre-Clinical & Product Development Services
Toxicokinetic Studies (TK)
Comprehensive Immune Profiling
Cell-Based Potency Assays
CMC Analytical Support Services
Media & Events
Quality Assurance Specialist II, Material Management
Scorpius BioManufacturing, a biologics CDMO focused on protein therapeutics, is hiring a Quality Assurance Specialist II, Material Management
February 9, 2024
How to Create a Successful Business and Technical Relationship with a CDMO
Scorpius BioManufacturing shares customer input on what makes for a successful business and technical relationship between sponsors and biologics CDMO.
February 6, 2024
How to Select the Right Biologics CDMO Partner
The article discusses essential & strategic considerations throughout the biologics CDMO selection process, including weighing options to make the best decisions.
December 1, 2023
Evaluating Biologics CDMOs: Tips for Crafting an RFP
Suggestions for designing an effective RFP for a biologics CDMO selection process, including how to approach RFP design & the information it should gather.
November 14, 2023
5 New Questions to Ask Before Signing with a Biologics CDMO
This article discusses the current value biologics CDMOs bring to their innovator customers and new questions for selecting a CDMO partner.
October 17, 2023
Top 6 Questions to Ask When Evaluating a Biologics CDMO
When selecting a biologics CDMO partner, an innovator must ask the right questions to make the best decision. This article shares six top considerations.
September 12, 2023
3 Trends Innovative Biologics CDMOs Are Embracing
Deep Dive: Top 3 Biologics Trends Shaping the Future with Scorpius.
July 31, 2023
Scorpius Highlighted In Drug Development & Delivery's Annual Report
Scorpius highlighted in Drug Development & Delivery's annual CDMO report
July 21, 2023
Emerging Horizons: The Evolving Biologics Trends
Unveiling the Future: Biologics Development & Key Industry Shifts with Scorpius.
June 23, 2023
How a Biologics CDMO Adds Value to mAbs Development & Manufacturing Programs
A look at a CDMO’s value throughout a monoclonal antibody (mAb) therapeutic's lifecycle
June 16, 2023